Kyle Bass gets first IPR win
The Patent Trial and Appeal Board has invalidated the claims of a patent covering Shire’s Gattex drug
The Patent Trial and Appeal Board has issued
two final written decisions invalidating claims of a patent covering Shire’s
Gattex drug. This marks the first success by hedge fund manager Kyle Bass at
The claims of US...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.